Considering the second wave of COVID19 in India, the Central Government has prohibited the export of Remdesivir and Remdesivir Active Pharmaceutical Ingredients. The notification states that there has been a sudden demand of Remdesivir and Remdesivir Active Pharmaceutical Ingredients for treatment of COVID19 patients. In a statement issued on Sunday, Centre said: “India is witnessing